Moreover, miR-132-3p, which is frequently downregulated in AD and other tauopathies, directly targets MAPT mRNA to inhibit its expression, and its deletion in AD model mice leads to tau aggregation [44]. This evidence concerns the gene MAPT and Alzheimer disease.